the laboratory rabbit (Oryctolagus cuniculus) is widely used as a model for a variety of inherited and acquired human diseases. In addition, the rabbit is the smallest livestock animal that is used to transgenically produce pharmaceutical proteins in its milk. Here we describe a protocol for high-efficiency germline transgenesis and sustained transgene expression in rabbits by using the Sleeping Beauty (sB) transposon system. the protocol is based on co-injection into the pronuclei of fertilized oocytes of synthetic mrna encoding the sB100X hyperactive transposase together with plasmid Dna carrying a transgene construct flanked by binding sites for the transposase. the translation of the transposase mrna is followed by enzyme-mediated excision of the transgene cassette from the plasmids and its permanent genomic insertion to produce stable transgenic animals. Generation of a germline-transgenic founder animal by using this protocol takes ~2 months. transposon-mediated transgenesis compares favorably in terms of both efficiency and reliable transgene expression with classic pronuclear microinjection, and it offers comparable efficacies (numbers of transgenic founders obtained per injected embryo) to lentiviral approaches, without limitations on vector design, issues of transgene silencing, and the toxicity and biosafety concerns of working with viral vectors.
IntroDuctIon
The laboratory rabbit is the third-most-used experimental mammal (behind mice and rats) in the EU (http://eurlex.europa. eu/LexUriServ/LexUriServ.do?uri=COM:2010:0511:REV1:EN: PDF), being a prolific animal with a short generation time that can be raised in specific pathogen-free conditions. The rabbit is the primary source of polyclonal antibodies, and recent transgenic rabbit models are capable of a markedly increased level of antibody production 1,2 . Transgenic rabbits are also used as bioreactors for the production of pharmaceutical proteins. Ruconest, the second milk-born recombinant product worldwide, produced and purified from transgenic rabbit's milk, has already reached the EU market (http://www.pharming.com/ index.php?act=prod).
Rodents, rabbits and other mammals all have particular limitations and strengths as animal models in biomedical research, and they are best regarded as complementary to each other. One example is Alzheimer's disease research, in which animal models from additional species are expected to compensate for the limitations of mouse models and provide more reliable evaluation of novel diagnostic and therapeutic strategies 3 . Among the already existing transgenic rabbit strains, those that model cardiovascular diseases are the most important. The spontaneous mutant Watanabe heritable hyperlipidemic rabbit was a pioneering animal model of lipid metabolism and atherosclerosis 4 , and it was followed by more than twenty different transgenic rabbit models, which altogether contributed to the development of both hypolipidemic and/or antiatherosclerotic compounds 5 . The limitations of transgenic mouse models, which have failed to completely mimic the human phenotype of inherited long QT syndrome, an inborn arrhythmogenic heart disease, made it necessary to create transgenic rabbit models 6 . Owing to their large eyes, rabbits, along with other mid-sized and large animal models, are important in testing new treatments for and surgical methods in eye diseases 7 . Transgenic rabbits carrying a rhodopsin mutation have shown rod-dominant progressive retinal degeneration 8 , and they serve as pathophysiology models for new therapeutic treatments 9 .
Germline transgenesis in rabbits
Since the first transgenic rabbits were created by pronuclear microinjection 10 , this has been the method of choice in the majority of ~200 publications on transgenic rabbits. The efficiency of this method has not changed much: on average, ~1-5% of the pups born from embryo transfer are transgenic. In addition to this low transgenesis rate, the integration site and copy number of a plasmid-based transgene is uncontrolled; therefore, unwanted ectopic expression or transgene silencing might occur. Transgenesis by artificial chromosomes (yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs)) ensures improved expression patterns, because those large-sized vectors include most, if not all, of the regulatory regions and the expression domains of the gene of interest (GOI) 2, 11 . However, microinjection of transgenes cloned into artificial chromosomes is technically demanding owing to their large size and fragility, and the integrity of the chromosomally integrated transgene should be strictly controlled.
Lentiviral transgenesis was reported to be a promising and efficient novel tool in different nonrodent species, where the ineffective and expensive pronuclear microinjection was the only available method (for review see ref. 12) . Somewhat contrary to expectations, the first data on lentiviral transgenesis in rabbit revealed that, although the SIV-based lentiviral transduction resulted in high numbers of transgenic founders, the germline transmission rate was very low largely because of mosaic transgene expression in the founder animals, which makes this method unsuitable for upscaling in this species 13 .
In contrast with mouse, swine and ruminants, the efficiency of somatic cell nuclear transfer (SCNT) in rabbits by using standard methods is very low, regardless of the type of nuclear donor cells, and only a negligible percentage of offspring remain healthy and reach sexual maturity (puberty) [14] [15] [16] [17] . Therefore, this method has limited practical use in rabbit transgenesis.
Transgenesis with the SB transposon
Similarly to retroviruses, DNA transposons integrate into the chromosomes of the host cells, a feature that forms the basis of their use as gene vectors. In nature, these elements contain a gene encoding a transposase enzyme flanked by inverted terminal repeats (ITRs) that carry binding sites for the transposase. In the laboratory, transposons can be applied as bi-component vector systems, in which a DNA sequence of interest is cloned between the transposon ITRs and mobilized by supplementing the transposase enzyme in trans, as an expression plasmid or as in vitro-synthesized mRNA (Fig. 1a) . During transposition, the transposase excises the transposon-contained cargo sequence from its donor plasmid and integrates it into a chromosomal locus (Fig. 1b) . On the basis of fossil record of transposons that were active >10 million years ago in fish genomes, an ancient transposon was 'awakened' (molecularly reconstructed) and named Sleeping Beauty (SB) after the Grimm brothers' fairy tale 18 . SB was the first transposon that was ever shown to be capable of efficient transposition in vertebrate cells, thereby enabling new avenues for genetic engineering in animal model species (reviewed in ref. 19 ). In addition to SB, the piggyBac and Tol2 transposons have also been developed as gene transfer tools for vertebrate genetics 19 .
SB transposon-based gene delivery combines the advantages of retroviral vectors (permanent gene insertion into recipient genomes) with those of naked DNA molecules (simple, safe and inexpensive). Because transposition is a cut-and-paste mechanism that only involves DNA, transposon vectors can tolerate larger and more complex transgenes. The SB system is not strictly limited by the size of expression cassettes 20 . Indeed, inserts as large as BAC were recently shown to transpose with SB at reasonable efficiencies in mouse embryonic stem cells (ESCs) 21 . The desirable outcome when performing transgenesis is the integration of a single-copy transgene into a genomic locus that is not disturbing endogenous gene functions. The insertional spectrum of the SB transposon satisfies this criterion well, because it integrates at TA dinucleotides nearly randomly, resulting in ~60% of the SB transposon integrations being intergenic [22] [23] [24] [25] . SB transposon vectors have been shown to efficiently deliver a wide variety of transgene cassettes (reviewed in refs. 19, 26, 27) , including shRNA expression cassettes to obtain stable RNAi knockdown cell lines 28 , as well as cassettes inducing gain-of-function and loss-of-function gene mutations 19, 26, 27 . Importantly, the basic components of the transposon systems (i.e., the transposon ITRs and the transposase) are universally applicable for gene transfer; it is the cargo DNA cloned between the ITRs that is tailored to the intended use (i.e., mutagenesis, germline transgenesis or somatic gene therapy).
Because the transposase is only transiently present in the cell, the integrated transposon is stable (will not undergo further rounds of transposition). This feature makes transposons easily controllable DNA delivery vectors that can be used for versatile applications, including germline gene transfer. A hyperactive variant of the SB transposase, called SB100X, was recently developed by in vitro evolution 29 , and it was shown to support efficient germline transgenesis in mice [29] [30] [31] , rats 30, 31 , rabbits 30 and pigs 32, 33 . The SB100X-mediated protocol was optimized by carefully titrating the relative amounts of transposase and transposon to obtain optimal rates of transgenesis to generate founders, and it was extensively evaluated for efficacy, toxicity, mosaicism, germline transmission, insertion site preferences, transgene copy number and silencing. Genotyping of numerous transgenic lines produced by SB transposition demonstrated single-copy integrations of the transposon as expected from the cut-andpaste integration reaction catalyzed by the SB transposase 30 . The number of integrations per genome was shown to be dependent on and hence controllable by the concentration of both components of the transposon system in the injection cocktail 30 . One of the most important aspects of using this transposon-mediated transgenic protocol is that no major mosaicism was observed, and transgene expression was maintained for several generations in all species tested. The high germline transmission rate using this protocol is in sharp contrast to any current nonviral or viral approach to transgenesis. This is probably because of the very nature of transgene integration: transposition results in precise (the ends of the integrating DNA are well defined) genomic integration of monomeric transgene units within a short time frame after administration, thereby minimizing mosaicism. Furthermore, unlike retroviral vectors [34] [35] [36] [37] , SB100X transposasecatalyzed transgene integration does not seem to trigger transcriptional silencing 24, 30 . Therefore, the application of the SB transposon system described here can significantly enhance the rabbit genomic toolbox.
Limitations
DNA transposons, including SB, piggyBac and Tol2, are regulated by overproduction inhibition, which means that overexpression of the transposase has a negative effect on the efficiency of transposition 24, 38 . The practical consequence of this phenomenon is that an optimal ratio of transposon donor plasmid and transposase mRNA needs to be established. As a rule of the thumb, the injection mixture should contain 5 ng/µl SB100X mRNA and 0.4 ng/µl transposon donor plasmid for an SB vector of a total size of ~6.1 kb (containing an ~2.5-kb transgene cassette) 29 . For larger transgenes, the concentration of the donor plasmid in the microinjection mixture has to be increased to maintain optimal molar ratios between transposon and transposase. It has been found that embryos tolerate concentrations of transposon donor plasmid up to 2 ng/µl in mice 29 .
Experimental design
The generation of transgenic rabbits by SB-mediated transgenesis is achieved through microinjection of a plasmid carrying a GOI cloned between the ITRs of SB, and synthetic transposase mRNA ( Fig. 1) into the pronucleus of a zygote, with frequencies of transgenic founders (per born live pup) of 15% or higher 30 . The protocol consists of the following major stages:
Preparation of SB transposon components for microinjection (Steps 1-26).
This includes molecular cloning of a GOI into SB transposon vectors; preparation of mRNA encoding the transposase by in vitro transcription; and preparation of a nucleic acid mixture consisting of the purified transposon plasmid and the transposase mRNA. Synthetic mRNA encoding the SB100X transposase can be produced from either the pCMV(CAT)T7-SB100X or the pcGlobin2-SB100X plasmids 29 (see Reagents). The latter vector supports in vitro synthesis of SB100X mRNA containing zebrafish β-globin 5′-and 3′-UTRs and a 30-mer synthetic poly(A) sequence from a T7 promoter 39 .
Transgenesis with SB in rabbits (Steps 27-49). This includes preparation of donor animals, superovulation of donors, collection of zygotes, microinjection of the nucleic acid mixture into zygotes and transfer of the microinjected embryos into surrogate mothers. The exact timing of superovulation and embryo collection is crucial, and it needs to be optimized to obtain sufficient numbers of freshly fertilized, one-cell-stage oocytes with clearly visible pronuclei. In contrast with mouse, rat and swine, the early development of rabbit embryos is rapid; therefore, it could easily happen that some of the embryos will be in the two-cell stage by the time the embryo collection is finished. For the same reason, it is not suggested to substantially increase the number of donor does per experimental day.
Genotyping of transgenic animals (Steps 50-76). This includes PCR-based analysis of F 0 and F 1 offspring to establish founders and germline transmission. A simple, quick PCR test can be applied to determine the presence of integrated transposon sequences from genomic DNA samples. The PCR primers amplify sequences in the left ITR of SB; thus, this protocol can be universally applied regardless of the GOI that was cloned into the SB vector. To assess the copy numbers of integrated transposons and map the genomic integration sites, a ligationmediated PCR (LMPCR) procedure is applied 40 . The procedure consists of a restriction enzyme digest of the genomic DNA, ligation of an oligonucleotide adapter to the ends of the fragmented DNA, PCR amplification of a transgene or genomic DNA junction in two rounds of nested PCR with primers specific to the adapter and to the ITRs of the SB transposon, and sequencing of the junctions to map the insertion to the reference genome 41 . Finally, a locus-specific PCR is applied to distinguish and track the individual integrations in the F 1 and later generations.
MaterIals

REAGENTS
Animals
Ten donor and ten recipient rabbits are sufficient to produce at least two independent transgenic founders in a well-managed animal unit with trained personnel. The most frequently used breed for transgenesis is the New Zealand White (Harlan Laboratories), but depending on the aim of the experiment it could be replaced with Hycole (Sarl Hycole) or ZIKA hybrid rabbits (Dr Zimmermann, Schweizerhof). In some countries, local breeds are also successfully used, e.g., Japanese White rabbits in Japan and China (KBT Oriental). Laboratory rabbits can also be obtained from the distributors of Charles River (Charles River Laboratories International) or from authorized local breeders. The rabbit does should be sexually mature and at an age of 16-20 weeks, weighing 3.0-3.5 kg on average. The rabbit bucks should be at least 18-20 weeks old to provide good-quality semen ! cautIon Experiments involving rabbits must conform to relevant governmental and institutional regulations. Animal handling requires special license(s • • 
2|
Transfer at least 5 µg of transposon donor plasmid in 400 µl of TE buffer into a 1.5-ml tube, and then add 400 µl of phenol/chloroform/isoamyl alcohol to the tube. ! cautIon This is a hazardous chemical. Avoid contact with skin, eyes and airways.
3|
Vortex the tube for 15 s and leave it on the bench for 2 min. Repeat this step three times to completely inactivate residual RNase.
4|
Centrifuge the tube at 12,000g for 5 min at room temperature.
5|
Transfer the top layer to a new, RNase-free 1.5-ml tube and add 400 µl of chloroform/isoamyl alcohol. ! cautIon This is a hazardous chemical. Avoid contact with skin, eyes and airways.
6|
Vortex the tube for 15 s, and centrifuge it at 12,000g for 5 min at room temperature.
7|
Transfer the aqueous top layer, containing the DNA, to a new RNase-free 1.5-ml tube, add a one-tenth volume of 3 M sodium acetate and 2.5 volumes of ethanol, vortex the tube briefly and precipitate the DNA for 30 min at −20 °C.
8|
Spin down the mixture at 12,000g for 15 min at 4 °C and discard the supernatant.
9|
Wash the pellet in cold 70% (vol/vol) ethanol (RNase-free) by keeping the ethanol on the pellet for 10 min on ice, centrifuge it at 12,000g for 1 min at 4 °C and discard the supernatant. Repeat this step to completely remove any residual chemicals that may not be tolerated by the embryos.  crItIcal step DEPC is not tolerated by the embryos, and RNase-free solutions that come in contact with the injected material should be purified by filtration. Therefore, use filtered, RNase-free water for the preparation of 70% (vol/vol) ethanol.
10| Air-dry the pellet for 5-10 min and resuspend it in 100 µl of EmbryoMax injection buffer.
11|
Measure the concentration of the plasmid DNA with a NanoDrop spectrophotometer.
12| Make a 50 ng/µl dilution of the plasmid in EmbryoMax injection buffer. This dilution can be used later for the preparation of the final injection mixture (Steps 25 and 26).  pause poInt The plasmid stock and its dilution can be stored (preferably at −80 °C) until use for up to 2 years.
13|
Thaw the plasmid DNA immediately before the preparation of the microinjection mixture (Step 25).
preparation of the transposase mrna • tIMInG 10-14 h 14| Linearize at least 2 µg of the pcGlobin2-SB100X plasmid with ClaI digestion; 1 µg of linearized plasmid will be necessary for one round of mRNA synthesis. Check complete linearization on a 1% (wt/vol) agarose gel.  crItIcal step Supercoiled plasmid DNA runs faster, whereas open circular plasmid runs slower on agarose gel than the linear form. After complete digestion, the bands corresponding to the open circular and supercoiled forms of the plasmid should be no longer visible on the gel. Consequently, linearized plasmid DNA produces a single band corresponding to the size of the plasmid when compared with a linear DNA ladder size marker.
15|
Prepare the digested plasmid RNase-free by phenol/chloroform extraction as described in Steps 2-10. In Steps 2 and 5, set the volumes of the digested plasmid DNA, the phenol/chloroform/isoamyl alcohol and the chloroform/isoamyl alcohol to 100 µl each. This will decrease the liquid volume during precipitation and improve DNA recovery.
16| Measure the concentration of the linearized plasmid DNA with a NanoDrop spectrophotometer.
17|
Synthesize the mRNA by using the mMessage mMachine T7 kit according to the manufacturer's instructions.
18|
After mRNA synthesis, perform the Turbo DNase treatment and phenol/chloroform extraction suggested in the mMessage mMachine T7 kit manual, with the modification that after the isopropanol precipitation following the phenol/chloroform extraction wash the pellet twice in cold 70% (vol/vol) ethanol. Use filtered, RNase-free water for the preparation of 70% (vol/vol) ethanol. Air-dry the pellet for 5-10 min.
19|
Resuspend the mRNA in 20 µl of filtered, RNase-free water.  pause poInt The in vitro-synthesized mRNA can be stored at −80 °C for 6 months.
20|
Measure the concentration of the in vitro-synthesized mRNA with a NanoDrop spectrophotometer. The typical yield is around 1 µg/µl.
21|
Prepare a 1% (wt/vol) agarose gel by using nuclease-free TBE buffer, Milli-Q water treated with DEPC and agarose powder. ! cautIon DEPC is a hazardous chemical. Avoid contact with skin, eyes and airways.
22| Load 1 µl of the in vitro-synthesized mRNA (Step 19) in RNA loading buffer (supplied in the mMessage mMachine T7 kit) and a double-stranded DNA size marker, and then run the gel. The SB100X mRNA prepared with the T7 promoter on the ClaI-digested pcGlobin2-SB100X runs on a normal agarose gel as one band between 700 and 800 bp in length (Fig. 2) .
? trouBlesHootInG 23| Prepare a 10 ng/µl dilution of the mRNA (Step 19) in EmbryoMax injection buffer and freeze 5-µl aliquots of this dilution.  crItIcal step It is advisable to test new batches of the EmbryoMax injection buffer for accidental presence of RNase (see Reagent Setup), as the manufacturer does not guarantee that it is RNase-free.  pause poInt The 10 ng/µl mRNA dilutions can be stored at −80 °C for 6 months.
preparation of the microinjection mixture • tIMInG 1 h 24| Thaw one aliquot of the 10 ng/µl mRNA solution immediately before the preparation of the microinjection mixture (Step 25).  crItIcal step Avoid repeated thawing and re-freezing of mRNA stocks, as it may cause mRNA degradation.
25| Prepare 5 µl of donor (transgene) plasmid (from the stock solution prepared in
Step 12) in a concentration of 0.8 ng/µl in EmbryoMax injection buffer.
26|
Mix the mRNA and donor plasmid solutions at a 1:1 ratio to create the final microinjection mixture. Prepare 2-µl aliquots of the final microinjection mixture.  pause poInt Frozen aliquots of the microinjection mixture may be stored at −80 °C for a couple of months.
superovulation and insemination of zygote donors
• tIMInG 5 d 27| To produce zygotes for pronuclear injection of the SB transposon vectors, superovulate 3-8 rabbit does (3-3.5 kg of body weight) by one of the following two superovulation procedures described as options A or B (Fig. 3) , and then mate or artificially inseminate them with buck semen from the same breed.  crItIcal step The timing of superovulation is crucial (see Experimental design); therefore, if you are using superovulation option B, it is practical to introduce both PMSG and hCG at 13:00 in the appropriate days, allowing embryo collection 20 h after the hCG injection and mating (i.e., in the morning on the following day).
Zygote collection • tIMInG 1-2 h  crItIcal Trained personnel with the appropriate institutional experimental permissions are required for performing Steps 28-33. 28| Euthanize the donor females with a mixture of 0.8 ml of 2% xylazine and 1.4 ml of 10% (wt/vol) ketamine i.v. at 9:00 (Fig. 3) .
29|
Rinse each donor animal's abdomen with 70% (vol/vol) ethanol and firmly remove the skin from the abdomen.
30|
Incise the peritoneum.
31|
Collect the reproductive organs (ovaries, oviducts and the cranial parts of the uterus horns; Fig. 4a ) and place them into PBS in a dish on a warm plate at 38.5 °C.  crItIcal step The reproductive organs are surrounded by fat tissue. Care must be taken to avoid scraping or damaging the oviduct.
32|
Place your capillary (GC100-T15) into the microcapillary holder. Place 2-3 drops of PBS + 20% (vol/vol) FCS medium into a 35-mm cell culture dish, overlay the droplets with mineral oil and place the dish into a CO 2 incubator at 38.5 °C.
33|
Collect zygotes 20 h after hCG treatment and mating (Step 27). Insert an 18-gauge mixing needle connected to a 20-ml syringe from the uterus side (if this is not possible, try to wash from the ovary side). Flush each oviduct with prewarmed (to 38.5 °C) PBS + 20% (vol/vol) FCS into 35-mm cell culture dishes. By counting the ovulatory follicles on the ovaries, the number of expected oocytes can be estimated (Fig. 4b) .  crItIcal step The oviduct should be thoroughly rinsed with culture medium. ? trouBlesHootInG 34| Place 3-4 drops of PBS + 20% (vol/vol) FCS medium into a 100-mm cell culture dish, and separate healthy zygotes from debris (Fig. 4c) by washing them through the medium drops. Good-quality embryos are free of cumulus cells, and they have two easily detectable pronuclei. Place the washed zygotes into the medium droplets overlayed with mineral oil (Step 32), and place the dish into a CO 2 incubator at 5% CO 2 and 38.5 °C until microinjection, for an hour.  crItIcal step Debris should be completely removed from the medium for optimal microinjection. 37| Place 20-40 zygotes into the drop and place the slide under a stereoscopic microscope (Fig. 4d) .  crItIcal step Do not handle too many zygotes at once.
38|
Place the depressed slide onto the heated stage of the microinjection microscope.
39|
Adjust the air-driven holding capillary to an angle of 35-40°, and then carefully dip it into the medium droplet in the depressed microscope slide. Fill the capillary with a minimal amount of medium and catch the first embryo by a slight negative pressure.
40|
Fill the injection capillary (GC100-TF15) by placing the base of the capillary into the Eppendorf tube containing the microinjection mixture kept on ice. Wait for 10 s until the mixture reaches the tip of the capillary. Insert the injection capillary into the connector piece and dip it into the medium droplet. Position it to the zygote.  crItIcal step Prevent breakage of your capillaries. Remove all air bubbles from the injection capillary.
41| Position your zygote; the best position is when the female and the male pronuclei are aligned in a row equatorially. Focus your microscope to the male pronucleus (usually the larger one), and adjust your injection capillary to see the tip of it sharply when it is in a 12 o'clock position. Keep your injection capillary parallel to the pronucleus (Fig. 4e) .
Penetrate the zygote and the pronucleus, and then inject carefully by pushing your syringe or automatic microinjector. Withdraw the capillary when the male pronucleus is swelling (Fig. 4f) . Microinject all viable zygotes one by one.  crItIcal step Be sure that you penetrate the pronucleus, because it is very flexible. The clearly visible swelling of the pronucleus is an indication of injecting ~2-3 pl of mRNA or plasmid solution. The female pronucleus can also be injected. In some cases, the female pronucleus is more visible in rabbits (rabbit zygotes can be darker than those of rodents); however, it is smaller and more difficult to inject.  crItIcal step If your injection capillary becomes clogged, replace it with a new one.  crItIcal step Carefully separate injected and uninjected zygotes to prevent mixing.
reimplantation of injected zygotes • tIMInG 15-30 min per recipient
 crItIcal Trained personnel with the appropriate institutional experimental permissions are required for performing these steps. 42| To prepare recipient does, apply a single i.m. injection of 0.25 ml of GnRH 24 h before embryo transfer (Fig. 3) . Remove forage from recipient does 12-14 h before embryo transfer. 43| Culture the microinjected embryos for 1 h in 5% CO 2 at 38.5 °C before reimplantation, and then select the embryos most suitable for embryo transfer (Fig. 4g) . ? trouBlesHootInG 44| Anesthetize recipient females with a mixture of 5 mg/kg body weight 2% (wt/vol) xylazine and 44 mg/kg body weight 10% ketamine i.v. Anesthesia lasts for 30-45 min.  crItIcal step Introduce the ketamine and xylazine solution stepwise and slowly. Fast administration might cause bradycardia.
45|
Remove the remaining urine with gentle massage of the lower part of the donor's body. Shave the abdominal region of the anesthetized recipient doe and clean it with a surgical soap solution such as Betadine. Place and fix the recipient doe in a hanging position. Introduce the endoscopic trocar (Veress pneumoperitoneum needle) through a small (1 cm) incision just above the umbilical point, as shown in Figure 4h .
46| Inflate the abdomen with air by using the rubber insufflation bulb. Remove the Veress trocar, and insert the arthro sheet with sharp obturator. Replace the obturator with the Hopkins telescope. Reinflate the abdomen.  crItIcal step Avoid injury of inner organs.
47|
Examine the ovaries of the recipients for signs of induced ovulation (such as those shown in Fig. 4a ). Do not transfer embryos into recipients that did not react to hormone treatment.
48|
Insert the cannula with its needle and find the ampulla of the oviduct. Exchange the needle with the transfer capillary filled with the embryos through the cannula and inject it gently with 10 µl of culture medium (Fig. 4i) . Remove the cannula with the empty capillary and the endoscope. Evacuate the air and close the abdomen with a suture wound clip. Transfer 8-12 embryos into each oviduct of a recipient doe. Endoscopic embryo transfer is minimally invasive 42 .
49|
Postoperative care: administer 1 ml of broad-spectrum antibiotics (Shotapen INJ) i.p. Place the recipient rabbit carefully into the home cage in the rabbit facility, and resupply forage when animals have fully recovered from the anesthesia. F 0 animals are born after a 30-to 32-d-long pregnancy of recipient does.  crItIcal step A specific feature of the rabbit embryo is a mucin layer, which is formed around the embryo in the oviduct. The thickness of the mucin layer is an important factor for successful implantation of rabbit embryos 43 . Therefore, it is important to transfer the embryos as soon as possible after a short in vitro culturing, at the end of which 20-80% of the injected rabbit embryos should be in two-cell stage before reimplantation. Keep in mind that owing to the rapid cell divisions during early embryogenesis, mosaicism is more probable in rabbits than in rodents. ? trouBlesHootInG Genotyping of transgenic animals-confirming transposon insertions by pcr • tIMInG 2.5 h 50| Isolate genomic DNA from ear biopsies of F 0 animals. A simple and reliable protocol for DNA isolation from tissue samples is available in Laird et al. 44 .
51| Set up a PCR in a 25-µl volume containing the components below: (Fig. 5b) , each in 50-µl final volumes. Include a negative control sample (genomic DNA isolated from a nontransgenic animal) as well. Follow the instructions of the enzyme supplier. To reach complete digestion, incubate the reaction for 3 h at 37 °C.  crItIcal step Always use high-quality genomic DNA as a template for PCR. Good-quality genomic DNA runs on an agarose gel as a dominant, high-molecular-weight band (Fig. 5c ).
55| Add 50 µl of phenol/chloroform/isoamyl alcohol to each tube. ! cautIon This is a hazardous chemical. Avoid contact with skin, eyes and airways.
56|
Vortex each tube for 10 s and leave it on the bench for 2 min. Repeat this step three times.
57|
Centrifuge each sample at 12,000g for 5 min at room temperature.
58|
Transfer the top layer (~50 µl) to a new 1.5-ml tube, add 5 µl (a one-tenth volume) of sodium acetate and 125 µl (2.5 volumes) of ethanol, shake it well and let the digested DNA precipitate for 30 min at −20 °C. 63| Measure the concentration of the digested DNA with a NanoDrop spectrophotometer. The typical yield is between 30 and 50 ng/µl.
64|
To check digestion, run 200 ng of each sample on a 1% (wt/vol) agarose gel. The digested DNA should run as a smear centered between 0.5 and 1 kb in size (Fig. 5d) .  pause poInt The digested genomic DNA samples can be stored at 20 °C for up to 1 year.
65|
Prepare the double-stranded linkers by mixing the Linker( + ) oligo with the Linker( − )BfaI or with the Linker( − )DpnII oligo (table 1) in separate tubes at a final concentration of 10 pmol/µl of each oligo in 100 µl of TE buffer containing 50 mM NaCl.
66|
Place the tubes containing the oligonucleotide solutions into a boiling water bath for 2 min, switch off the heating and leave the tubes in the bath overnight to allow a slow cool down and hybridization of the two single-stranded oligonucleotides to form the double-stranded linker.  pause poInt The annealed double-stranded oligonucleotides can be stored at −20 °C for up to 1 year.
67|
Ligate the BfaI linkers and the DpnII linkers to the corresponding BfaI-and DpnII-digested genomic DNA samples, respectively (Fig. 5b) . Set up the ligation reaction containing the components below, and incubate it overnight at 16 °C. The 'X' indicates that the amount will vary according to the concentration. 72| Run a 10-µl aliquot of the PCR product on a 1% (wt/vol) agarose gel. An example result is shown in Figure 5e . Each band represents a unique transposon (transgene) genomic integration.
73|
If strong, distinct bands are visible, isolate them from the gel by using the QIAquick gel extraction kit according to the manufacturer's instructions, and then sequence them. Multiple bands often represent multiple integrations, and lower-intensity bands may represent mosaic integrations, all of which need to be isolated from the gel, subcloned and sequenced. One should be able to identify the TA target dinucleotides immediately flanking the ITR in the genomic sequence, the BfaI and/or DpnII recognition sites and the linkers that had been ligated to the DNA ends. The PCR amplifications applied in parallel on the BfaI-and DpnII-digested DNA methods help the user to recover all integrations. tracking individual transgene integration sites by locus-specific pcr • tIMInG 1 week 75| Design PCR primers matching the integration loci mapped in the founder animals (Step 74). Avoid designing primers that would bind to repetitive elements and thus amplify nonspecific PCR products. The BLAT search at the UCSC Genome Bioinformatics website directly provides a RepeatMasker annotation of the genomic loci where the SB transposons have integrated. When using BLAST at the NCBI website, select 'map viewer' for a given BLAST hit, and then select 'maps & options' and choose 'repeats' to see the RepeatMasker annotation. After the identification of genomic regions free of repetitive sequences in the neighborhood of the SB ITR, design at least one locus-specific primer with a T m between 55 and 60 °C and a length between 20 and 25 nt. Run a BLAT or BLAST search with the new primer sequences to make sure that they do not bind to other genomic locations. In addition, general rules for PCR primer design can be found, for example, at http://www.premierbiosoft.com/tech_notes/PCR_Primer_Design.html.
74|
76|
Perform the locus-specific PCR with the primer designed in Step 75 and primer Tbal (table 1) to trace specific transgene integrations by the presence or absence of an amplified product. To maximize the specificity of primer annealing to the genomic target, the use of touchdown PCR is recommended, consisting of 5-10 touchdown cycles in which the annealing temperature is decreased stepwise by 1 °C per cycle down to the final annealing temperature at ~2 °C below the T m of the lower T m primer, followed by 25 additional standard cycles. supplementary Figure 1 shows an example of locus-specific PCR test of a rat founder and its F 1 descendants.
? trouBlesHootInG Troubleshooting advice can be found in table 2. 
